M&T Bank
INBX

M&T Bank’s Inhibrx, Inc. Common Stock INBX Stock Holding History

M&T Bank’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,476
Closed -$751K – 1662
2024
Q1 		$751K Sell
21,476
-2,367
-10% -$86.3K ﹤0.01% 979
2023
Q4 		$906K Sell
23,843
-4,663
-16% -$99.9K ﹤0.01% 908
2023
Q3 		$523K Buy
28,506
+102
+0.4% +$2.13K ﹤0.01% 1066
2023
Q2 		$738K Buy
28,404
+6,600
+30% +$154K ﹤0.01% 980
2023
Q1 		$412K Buy
21,804
+3,988
+22% +$92.7K ﹤0.01% 1180
2022
Q4 		$438K Sell
17,816
-9,252
-34% -$272K ﹤0.01% 1159
2022
Q3 		$486K Sell
27,068
-6,104
-18% -$110K ﹤0.01% 1097
2022
Q2 		$376K Buy
33,172
+21,429
+182% +$315K ﹤0.01% 1111
2022
Q1 		$262K Buy
11,743
+975
+9% +$24.9K ﹤0.01% 1270
2021
Q4 		$470K Sell
10,768
-830
-7% -$33.2K ﹤0.01% 1058
2021
Q3 		$386K Hold
11,598
– – ﹤0.01% 1126
2021
Q2 		$319K Hold
11,598
– – ﹤0.01% 1235
2021
Q1 		$233K Hold
11,598
– – ﹤0.01% 1348
2020
Q4 		$382K Hold
11,598
– – ﹤0.01% 1210
2020
Q3 		$209K Buy
+11,598
New +$210K ﹤0.01% 1398

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

M&T Bank's INBX Position: Q2 2024 in Review

M&T Bank sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 21,476 shares — an estimated $751K sold.

M&T Bank first reported a position in INBX in Q3 2020 and held it in 15 quarters. The position peaked at $906K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • M&T Bank reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • M&T Bank sold 21,476 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $751K.
  • M&T Bank first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • M&T Bank's Inhibrx, Inc. Common Stock position peaked at $906K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on M&T Bank's 13F filing for Q2 2024, filed 31 Jul 2024.